ID

44778

Beschrijving

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01010373

Link

https://clinicaltrials.gov/show/NCT01010373

Trefwoorden

Versies (3)
  1. 01-09-15 01-09-15 -
  2. 13-04-21 13-04-21 - Dr. rer. medic Philipp Neuhaus
  3. 18-11-21 18-11-21 -
Houder van rechten

BioMAS Ltd

Geüploaded op

18 november 2021

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Acute Myeloid Leukemia NCT01010373

Engels

Eligibility Acute Myeloid Leukemia NCT01010373

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

confirmed diagnosis of primary aml or aml transformed myelodysplastic syndrome (mds) with fab classification other than m3 as proven by bone marrow aspiration.
Beschrijving

myelodysplastic syndrome; bone marrow; diagnosis; aspiration; confirmed; other; primary; fab

Datatype

boolean

Alias
UMLS CUI [1]
C3463824
UMLS CUI [2]
C0023467
age ≥60 years.
Beschrijving

age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of 0-2 (karnofsky >60%).
Beschrijving

ecog performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
adequate renal functions: serum creatinine < 2 times the upper limit of normal (uln).
Beschrijving

upper limit of normal (sgpt); upper limit of normal (sgot); serum creatinine; renal function; uln

Datatype

boolean

Alias
UMLS CUI [1]
C0232804
adequate hepatic function: serum ast and alt ≤ 3 x uln.
Beschrijving

hepatic function; serum; ast; uln; alt

Datatype

boolean

Alias
UMLS CUI [1]
C0232741
patients with reproductive potential must use an effective contraceptive method through the study. patients must receive contraceptive and/or fertility counseling prior to entering the study, i.e., information on sperm banking, etc.
Beschrijving

contraceptive; method; study

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Beschrijving

Exclusion Criteria

patients receiving any other investigational agents.
Beschrijving

other; agents

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
symptomatic cns involvement.
Beschrijving

cns involvement; symptomatic

Datatype

boolean

Alias
UMLS CUI [1]
C0449389
history of pancreatitis or active alcohol abuse.
Beschrijving

alcohol abuse; pancreatitis; active

Datatype

boolean

Alias
UMLS CUI [1]
C0085762
UMLS CUI [2]
C0030305
histologic diagnosis of fab m3 aml.
Beschrijving

diagnosis; fab

Datatype

boolean

Alias
UMLS CUI [1]
C0023487
life expectancy of less than 1 month.
Beschrijving

life expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
patient receives myelotarg (ozogamicin gemtuzumab).
Beschrijving

Mylotarg

Datatype

boolean

Alias
UMLS CUI [1]
C0876099
use of hematopoietic growth factors such as g-csf within 1 week prior to treatment initiation.
Beschrijving

growth factors; treatment; g-csf; week

Datatype

boolean

Alias
UMLS CUI [1]
C0079490
pregnant or lactating females.
Beschrijving

pregnant or lactating

Datatype

boolean

Alias
UMLS CUI [1]
C0549206
patient has known human immunodeficiency virus (hiv) infection or known hiv-related malignancy; patient has active hepatitis a, b or c infection.
Beschrijving

human immunodeficiency virus; active hepatitis; hepatitis a; malignancy; infection; related; hiv

Datatype

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019159
UMLS CUI [3]
C0348211
active, uncontrolled, systemic infection considered opportunistic, life threatening, or of clinical significance at the time of treatment, or any severe concurrent disease which, in the opinion of the investigator, would make the patient inappropriate for trial entry.
Beschrijving

systemic infection; life threatening; investigator; treatment; clinical; disease; severe; active; entry; time

Datatype

boolean

Alias
UMLS CUI [1]
C0243026
UMLS CUI [2]
C1517874
the patient has had congestive heart failure - new york heart association (chf-nyha) grade ii or higher, and/or myocardial infarction within the last 12 months, or any cardiac disorder which, in the opinion of the investigator, could put the patient at risk of clinically relevant arrhythmia.
Beschrijving

new york heart association classification; congestive heart failure; myocardial infarction; cardiac disorder; investigator; arrhythmia; grade; last; chf

Datatype

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0027051
Terug naar het begin van de pagina

Similar models

Eligibility Acute Myeloid Leukemia NCT01010373

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
myelodysplastic syndrome; bone marrow; diagnosis; aspiration; confirmed; other; primary; fab
Item
confirmed diagnosis of primary aml or aml transformed myelodysplastic syndrome (mds) with fab classification other than m3 as proven by bone marrow aspiration.
boolean
C3463824 (UMLS CUI [1])
C0023467 (UMLS CUI [2])
age
Item
age ≥60 years.
boolean
C0001779 (UMLS CUI [1])
ecog performance status
Item
ecog performance status of 0-2 (karnofsky >60%).
boolean
C1520224 (UMLS CUI [1])
upper limit of normal (sgpt); upper limit of normal (sgot); serum creatinine; renal function; uln
Item
adequate renal functions: serum creatinine < 2 times the upper limit of normal (uln).
boolean
C0232804 (UMLS CUI [1])
hepatic function; serum; ast; uln; alt
Item
adequate hepatic function: serum ast and alt ≤ 3 x uln.
boolean
C0232741 (UMLS CUI [1])
contraceptive; method; study
Item
patients with reproductive potential must use an effective contraceptive method through the study. patients must receive contraceptive and/or fertility counseling prior to entering the study, i.e., information on sperm banking, etc.
boolean
C0700589 (UMLS CUI [1])
other; agents
Item
patients receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1])
cns involvement; symptomatic
Item
symptomatic cns involvement.
boolean
C0449389 (UMLS CUI [1])
alcohol abuse; pancreatitis; active
Item
history of pancreatitis or active alcohol abuse.
boolean
C0085762 (UMLS CUI [1])
C0030305 (UMLS CUI [2])
diagnosis; fab
Item
histologic diagnosis of fab m3 aml.
boolean
C0023487 (UMLS CUI [1])
life expectancy
Item
life expectancy of less than 1 month.
boolean
C0023671 (UMLS CUI [1])
Mylotarg
Item
patient receives myelotarg (ozogamicin gemtuzumab).
boolean
C0876099 (UMLS CUI [1])
growth factors; treatment; g-csf; week
Item
use of hematopoietic growth factors such as g-csf within 1 week prior to treatment initiation.
boolean
C0079490 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating females.
boolean
C0549206 (UMLS CUI [1])
human immunodeficiency virus; active hepatitis; hepatitis a; malignancy; infection; related; hiv
Item
patient has known human immunodeficiency virus (hiv) infection or known hiv-related malignancy; patient has active hepatitis a, b or c infection.
boolean
C0019682 (UMLS CUI [1])
C0019159 (UMLS CUI [2])
C0348211 (UMLS CUI [3])
systemic infection; life threatening; investigator; treatment; clinical; disease; severe; active; entry; time
Item
active, uncontrolled, systemic infection considered opportunistic, life threatening, or of clinical significance at the time of treatment, or any severe concurrent disease which, in the opinion of the investigator, would make the patient inappropriate for trial entry.
boolean
C0243026 (UMLS CUI [1])
C1517874 (UMLS CUI [2])
new york heart association classification; congestive heart failure; myocardial infarction; cardiac disorder; investigator; arrhythmia; grade; last; chf
Item
the patient has had congestive heart failure - new york heart association (chf-nyha) grade ii or higher, and/or myocardial infarction within the last 12 months, or any cardiac disorder which, in the opinion of the investigator, could put the patient at risk of clinically relevant arrhythmia.
boolean
C0018802 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial